Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents
CA 2223032 A1 · Owner: Smithkline Beecham Corporation · Inventors: Del Vecchio, Alfred
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for identifying compounds having anti-viral activity against members of the herpes virus family. This method involves the identification of compounds which inhibit the interaction between the gene products of the herpes simplex virus-1 UL15 gene and the UL19 gene (VP5). Also provided are compounds identified by the method of the invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 11, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 11, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 11, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.